Page last updated: 2024-11-03

procaine and Basal Ganglia Diseases

procaine has been researched along with Basal Ganglia Diseases in 1 studies

Procaine: A local anesthetic of the ester type that has a slow onset and a short duration of action. It is mainly used for infiltration anesthesia, peripheral nerve block, and spinal block. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1016).
procaine : A benzoate ester, formally the result of esterification of 4-aminobenzoic acid with 2-diethylaminoethanol but formed experimentally by reaction of ethyl 4-aminobenzoate with 2-diethylaminoethanol.

Basal Ganglia Diseases: Diseases of the BASAL GANGLIA including the PUTAMEN; GLOBUS PALLIDUS; claustrum; AMYGDALA; and CAUDATE NUCLEUS. DYSKINESIAS (most notably involuntary movements and alterations of the rate of movement) represent the primary clinical manifestations of these disorders. Common etiologies include CEREBROVASCULAR DISORDERS; NEURODEGENERATIVE DISEASES; and CRANIOCEREBRAL TRAUMA.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
ASLAN, A1

Other Studies

1 other study available for procaine and Basal Ganglia Diseases

ArticleYear
[Studies of the action of novocaine (substance H3): eutrophic action and rejuvenation].
    Minerva medica, 1958, Sep-19, Volume: 49, Issue:75

    Topics: Aged; Arteriosclerosis Obliterans; Basal Ganglia; Basal Ganglia Diseases; Disease; Eyelids; Humans;

1958